Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%

Jul.29.2025
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.

Key Points:

 

·Project results: The "Our Futures Vaping Prevention Education program" in Australia has significantly reduced the likelihood of teenagers using e-cigarettes, with students involved in the program being 65% less likely to use e-cigarettes 12 months later compared to students who did not participate. 

 

·Research background: The program is funded by the current Australian government and is the first confirmed school-based electronic health intervention program in Australia that can prevent teenagers from using e-cigarettes. 

 

·Research methods: The randomized controlled trial involved 40 schools and over 5000 students, with the results published in The Lancet. 

 

·Project content: The program engages students through cartoon stories, quizzes, and classroom activities, co-designed by young people and teachers to align with national curriculum guidelines. 

 

·Public health significance: The latest data shows a decline in young people using e-cigarettes, with e-cigarette use being increasingly viewed as uncool and socially unacceptable among youth. 

 

·Future plans: The project will be expanded nationwide until 2028, with long-term tracking data expected to be available by 2026.

 


 

【2Firsts News Flash】According to the official website of the Australian government on July 29th, Australia's "Our Futures Vaping Prevention Education program" implemented in schools has achieved tangible results in preventing young people from using e-cigarettes.

 

This randomized controlled trial involved over 5,000 students from 40 schools, and its results were published on July 29th in the top health journal, The Lancet. The study found that students who participated in the program were 65% less likely to use e-cigarettes after 12 months compared to students who did not take part in the course. Additionally, 80% of students reported that the knowledge they gained would help them deal with e-cigarette-related situations in the future.

 

This project is funded by the current Australian government through the Medical Research Future Fund and the National Health and Medical Research Council. It is the first Australian school-based electronic health intervention program proven to prevent adolescents from using e-cigarettes.

 

This program attracts students and delivers information through cartoon stories, quizzes, and classroom activities. It is designed by young people and teachers together to align with the national curriculum.

 

These positive findings are consistent with the latest data on "Generation Vape," which shows a decreasing trend in youth e-cigarette use. E-cigarettes are increasingly being seen as uncool and socially unacceptable among young people.

 

"Our Future" e-cigarette project will be rolled out nationwide until 2028, with long-term tracking data expected to be available by 2026.

 

All high schools are eligible to register and participate in this project, and can do so by signing up immediately.

 

Minister Butler's statement:

 

"'Our Future' e-cigarette prevention education program is helping Australian teenagers make wise choices and resist e-cigarettes. It is smart, scalable, and evidence shows it is effective. This is the evidence-based prevention action we need to protect children's health. Young people are moving away from e-cigarettes. They see its nature - harmful, addictive, and pushed by big tobacco companies. This is proof of the power of education, community, and strong government action."

 

According to publicly available information, The Lancet is one of the oldest and most respected peer-reviewed medical journals in the world, alongside the New England Journal of Medicine, JAMA (Journal of the American Medical Association), and the British Medical Journal, often referred to as the "Big Four" international medical journals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Shenzhen SKE Technology has launched the FRESA PRO in the United States, a high-capacity rechargeable disposable vape featuring Fresh Lock electromagnetic valve supply control technology. The device combines a claimed capacity of up to 40,000 puffs, dual mesh coils, dual output modes and a transparent tank design. The launch reflects the high-capacity disposable vape segment’s shift from puff-count competition toward improved e-liquid management and device-level experience.
Aug.03
Iowa Enforces Vape Registry Law as Retailers Warn Product Limits Could Increase Store Pressure
Iowa Enforces Vape Registry Law as Retailers Warn Product Limits Could Increase Store Pressure
Iowa has begun enforcing its vape registry law, requiring vape products to be registered before they can be legally sold in the state. The move follows a decision by the U.S. Court of Appeals for the Eighth Circuit to lift an injunction that had blocked enforcement. Retailers have warned that tighter product availability rules could increase pressure on vape shops. One Iowa retailer said that if only a limited number of products remain available, many stores could face significant business challenges.
Aug.06
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations
News
Jun.26 by 2Firsts Perspectives